TRKYY yields 6.77% · MRK yields 2.76%● Live data
📍 TRKYY pulled ahead of the other in Year 1
Combined, TRKYY + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TRKYY + MRK for your $10,000?
Türkiye Sinai Kalkinma Bankasi A.S. operates as a development and investment bank in Turkey and internationally. The company engages in the industrial investments, energy and resource efficiency, environmental investments, renewable energy, sustainable tourism, women's employment and equal opportunity, occupational health and safety, investments in developing regions, education and health investments, R&D and innovation, and working capital financing activities. It also provides project finance for energy generation and power plants; electricity distribution and natural gas distribution projects; mergers and acquisitions; logistics, transportation, and telecommunications; and public - private partnership projects. In addition, the company offers wholesale banking and SME financing, foreign trade finance, working capital financing, and machinery and equipment leasing services; letter of guarantees/external guarantees/letter of credits; and export/Eximbank endorsement, and country loans. Further, it provides corporate finance products and services, such as public offering preparation and brokerage, debt instrument issues, and mergers and acquisitions advisory; derivatives products, such as forwards, options, caps and floors, swaps, and swaptions; repo, warrant, and foreign derivative transactions; securities loans; brokerage for stock and bonds trading; and portfolio management and investment advisory services. Additionally, the company offers financial planning strategy, feasibility, valuation, and restructuring services, as well as sectoral analysis studies; and engineering and technical advisory, real estate appraisal, economic research, and sustainability consultancy services. Türkiye Sinai Kalkinma Bankasi A.S. was incorporated in 1950 and is headquartered in Istanbul, Turkey.
Full TRKYY Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.